There was an increase in the rate of CD3+ T cells per DOG-1+ tumour cells for IM-PD/SU-treated group compared to IM-PD group (p = 0.002; Fig. 2a), although CD8+ expression of CD3+ T cell did not differ between the groups (Fig. 2b). This evidence concerns the gene CD8A and neoplasm.